Forgo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-08-2024
- Paid Up Capital ₹ 0.10 M
as on 26-08-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.18 Cr
as on 26-08-2024
- Satisfied Charges ₹ 1.25 Cr
as on 26-08-2024
- Revenue -27.94%
(FY 2023)
- Profit -87.08%
(FY 2023)
- Ebitda -146.42%
(FY 2023)
- Net Worth -5.19%
(FY 2023)
- Total Assets 11.97%
(FY 2023)
About Forgo Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.18 Cr. The company has closed loans amounting to ₹1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neenu Mittal and Ashish Mittal serve as directors at the Company.
- CIN/LLPIN
U24230CH2005PTC028622
- Company No.
028622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Forgo Pharmaceuticals Private Limited offer?
Forgo Pharmaceuticals Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, Common Disease Medicines, Anaemia Medicine, Hand Sanitizers & Personal Hygiene, Herbal Soaps, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Forgo Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Mittal  | Director | 05-Jul-2005 | Current |
| Neenu Mittal | Director | 05-Jul-2005 | Current |
Financial Performance of Forgo Pharmaceuticals.
Forgo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.94% decrease. The company also saw a substantial fall in profitability, with a 87.08% decrease in profit. The company's net worth dipped by a decrease of 5.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Forgo Pharmaceuticals?
Unlock access to Forgo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Nov 2022 | ₹1.50 Cr | Open |
Axis Bank Limited Creation Date: 28 Sep 2020 | ₹2.25 Cr | Open |
State Bank Of India Creation Date: 15 Feb 2010 | ₹0.32 M | Open |
How Many Employees Work at Forgo Pharmaceuticals?
Unlock and access historical data on people associated with Forgo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Forgo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Forgo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
